NFKB1 and B-cell chronic lymphocytic leukemia: Using this method, we identified activation of distinct signaling pathways in IgM U-CLL compared with IgM M-CLL and IgG M-CLL, including BcR signaling, NF-κB signaling, MAPK-ERK signaling, and others (Supplementary Tables 2–4).